Thermo Fisher Scientific Slides as Investors Appear to Take Profits Ahead of Earnings

2026-10-08

Investivoq PriceTracker

Thermo Fisher Scientific (TMO) is down 3.7% today. Here is some analysis on what might have caused this price movement.

Analysis: There does not appear to be a major new company-specific negative announcement driving the drop. The move looks more likely tied to profit-taking after a strong run, a cautious setup ahead of third-quarter results on October 21, 2026, and broader pressure on richly valued stocks as Treasury yields moved higher. This could be because investors are waiting for fresh evidence that biopharma and laboratory spending trends remain strong enough to support recent optimism.

Details:

Thermo Fisher recently said it will release third-quarter 2026 results before the market opens on October 21, which can make traders more defensive in the days leading into earnings.

The company has not posted a fresh negative press release in its recent newsroom updates, which suggests the decline may be more sentiment-driven than news-driven.

Earlier in 2026, Thermo Fisher reported second-quarter results that topped expectations, helping support a strong rally and raising the odds of short-term profit-taking after recent gains.

Broader market conditions also turned less friendly as oil prices and Treasury yields climbed, a backdrop that often weighs on premium-valued healthcare and tools names.

Sources:

Thermo Fisher Scientific Investor Relations, AP News, TradingKey

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$TMO Insider Trading Activity

$TMO insiders have traded $TMO stock on the open market 94 times in the past 6 months. Of those trades, 0 have been purchases and 94 have been sales.

Here’s a breakdown of recent trading of $TMO stock by insiders over the last 6 months:

MARC N CASPER (Chairman & CEO) has made 0 purchases and 85 sales selling 55,158 shares for an estimated $32,841,663.
MICHAEL D SHAFER (Executive Vice President) has made 0 purchases and 2 sales selling 25,500 shares for an estimated $15,300,000.
LISA P. BRITT (Sr. VP and Chief HR Officer) has made 0 purchases and 2 sales selling 17,290 shares for an estimated $10,407,092.
GIANLUCA PETTITI (President & COO) has made 0 purchases and 4 sales selling 4,933 shares for an estimated $2,950,296.
JOSEPH R. HOLMES (VP & Chief Accounting Officer) sold 420 shares for an estimated $245,620

To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

EARLY ACCESS

Receive TMO Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$TMO Hedge Fund Activity

We have seen 1,097 institutional investors add shares of $TMO stock to their portfolio, and 1,264 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 8,503,527 shares (+inf%) to their portfolio in Q2 2026, for an estimated $4,263,328,296
FMR LLC added 3,308,052 shares (+30.7%) to their portfolio in Q2 2026, for an estimated $1,658,524,950
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 3,114,527 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,561,499,256
DODGE & COX added 3,029,037 shares (+11767.4%) to their portfolio in Q2 2026, for an estimated $1,518,637,990
BANK OF AMERICA CORP /DE/ removed 1,638,138 shares (-29.6%) from their portfolio in Q2 2026, for an estimated $821,296,867
PRICE T ROWE ASSOCIATES INC /MD/ removed 1,199,135 shares (-19.0%) from their portfolio in Q2 2026, for an estimated $601,198,323
PICTET ASSET MANAGEMENT HOLDING SA removed 987,673 shares (-47.9%) from their portfolio in Q2 2026, for an estimated $495,179,735

To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

$TMO Government Contracts

We have seen $93,915,453 of award payments to $TMO over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

MAINTENANCE OF THERMO FISHER SCIENTIFIC MASS SPECTROMETERS: $1,830,683

To track government contracts to publicy traded companies, check out Investivoq's government contracts dashboard. You can access data on government contracts through the Investivoq API government contracts endpoint.

$TMO Congressional Stock Trading

Members of Congress have traded $TMO stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $TMO stock by members of Congress over the last 6 months:

REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 07/10.
REPRESENTATIVE DWIGHT EVANS sold up to $15,000 on 05/07.

To track congressional stock trading, check out Investivoq's congressional trading dashboard. You can access data on congressional stock trades through the Investivoq API Congress trades endpoint.

$TMO Price Targets

Multiple analysts have issued price targets for $TMO recently. We have seen 9 analysts offer price targets for $TMO in the last 6 months, with a median target of $570.0.

Here are some recent targets:

Vijay Kumar from Evercore ISI Group set a target price of $570.0 on 07/06/2026
Eve Burstein from Bernstein set a target price of $520.0 on 06/26/2026
David Westenberg from Piper Sandler set a target price of $510.0 on 06/11/2026
Sidharth Sahoo from HSBC set a target price of $540.0 on 06/03/2026
Mike Polark from Wolfe Research set a target price of $535.0 on 06/02/2026
Brandon Couillard from Wells Fargo set a target price of $615.0 on 05/08/2026
Catherine Schulte from Baird set a target price of $639.0 on 04/24/2026

This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.